Stocky Stocky Start free trial
Tokyo · Stocky rates: Hold

MEDIKIT CO LTD (7749.T)

¥2,890.00 ▲ +1.01% as of 24 Aug, 12:47

Stocky turns companies like MEDIKIT CO LTD into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
Stocky Verdict
62
/ 100
Hold

What Stocky thinks

Hold. 7749.T scores near midpoint across Growth (55.5) and Value (61) metrics, reflecting a mature business lacking standout operational momentum or valuation edge. Leadership Alignment (62.5) is neutral; insufficient data flags specific founder-CEO alignment or dilution patterns to lift conviction.

Compounder Score
61/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
63/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
100/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
61/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for MEDIKIT CO LTD:

62
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 62/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

63
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

100
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

MEDIKIT CO LTD (7749.T) — frequently asked

Is MEDIKIT CO LTD (7749.T) a good investment right now?

Stocky rates MEDIKIT CO LTD (7749.T) at 62/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Hold. 7749.T scores near midpoint across Growth (55.5) and Value (61) metrics, reflecting a mature business lacking standout operational momentum or valuation edge. Leadership Alignment (62.5) is neutral; insufficient data flags specific fo

What is 7749.T's Stocky Verdict?

7749.T's current Stocky Verdict is 62/100, placing it in the "Hold" band. This composite combines a 61/100 Compounder score, 63/100 Leadership, Moat rating, and analyst signal.

Does MEDIKIT CO LTD have a competitive moat?

Stocky hasn't finalised a Moat Score for MEDIKIT CO LTD yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is MEDIKIT CO LTD's leadership aligned with shareholders?

MEDIKIT CO LTD scores 63/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to 7749.T?

MEDIKIT CO LTD's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to MEDIKIT CO LTD.

This is just the surface. See the whole picture on MEDIKIT CO LTD.

Sign up free and unlock the full analysis on 7749.T — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering 7749.T — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for 7749.T.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how 7749.T changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to 7749.T?" · "Is 7749.T overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
62
/ 100 · Hold

See MEDIKIT CO LTD the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in 7749.T would be worth today.
Practice portfolio
Buy 7749.T with virtual money and track it — zero risk.
Free · no real money · learn by doing Open 7749.T in Stocky →

Or jump straight to the interactive dashboard for 7749.T in the app.

Get 7749.T live scores, charts & analyst targets in StockyOpen in Stocky →